2022
|
Astellas Pharma
|
NAT.C08.EB Assessing Human Rights Risks and Impacts Results
Does the company publicly disclose the results of its assessments, which may be aggregated across its operations and locations?
The company discloses the result of human rights risks from its internal and external hotlines, however, there is no evidence that the company publicly discloses the results of its assessments, which may be aggregated across its operations and locations.